Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2005
04/07/2005WO2005030968A2 Actin regulatory elements for use in plants
04/07/2005WO2005030967A2 Crop plant cystatin proteinase inhibitors and methods of use
04/07/2005WO2005030966A2 Regulation of plant biomass and stress tolerance
04/07/2005WO2005030965A2 Expansin polypeptides
04/07/2005WO2005030964A1 Hiv pharmaccines
04/07/2005WO2005030963A1 Leader sequences for use in production of proteins
04/07/2005WO2005030962A1 Synthetic heparanase molecules and uses thereof
04/07/2005WO2005030961A1 Novel nerve stem cell marker
04/07/2005WO2005030960A1 Staple type oligonucleotide and drug comprising the same
04/07/2005WO2005030957A1 Method for in vitro evolution of polypeptides
04/07/2005WO2005030952A1 Method of analyzing haplotype
04/07/2005WO2005030949A1 Methods and materials for the production of shikimic acid
04/07/2005WO2005030948A1 Polypeptide having rnase iii activity
04/07/2005WO2005030947A2 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
04/07/2005WO2005030945A1 New acylglycerol acyltransferase-like protein mgat-x1 and uses thereof
04/07/2005WO2005030944A1 A gene encoding an enzyme for catalyzing biosynthesis of lignan, and use thereof
04/07/2005WO2005030943A1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof
04/07/2005WO2005030942A1 Plants with reduced activity of a class 3 branching enzyme
04/07/2005WO2005030941A1 Plants with increased activity of a class 3 branching enzyme
04/07/2005WO2005030931A2 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent
04/07/2005WO2005030928A2 PORCINE INVARIANT CHAIN PROTEIN, FULL LENGTH cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
04/07/2005WO2005030927A2 Methods and compositions for in vivo inflammation monitoring
04/07/2005WO2005030803A1 Therapeutic molecules
04/07/2005WO2005030802A2 Antigens for an east coast fever vaccine
04/07/2005WO2005030800A2 Oligonucleotide analog and method for treating flavivirus infections
04/07/2005WO2005030799A1 Antisense compound and method for selectively killing activated t cells
04/07/2005WO2005030787A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
04/07/2005WO2005030269A1 Endotoxin-nonresponsive model animal
04/07/2005WO2005030261A1 Oncolytic adenoviral vectors encoding gm-csf
04/07/2005WO2005030260A1 Bispecific oligonucleotide for the treatment of cns malignancies
04/07/2005WO2005030259A2 Nucleic acid-lipophilic conjugates
04/07/2005WO2005030256A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES
04/07/2005WO2005030255A1 METHOD OF TREATING DIABETES BY INHIBTING DEGRADATION OF AT LEAST ONE OF CREBL1, ATF6 and HNF-4α BY HtrA2
04/07/2005WO2005030139A2 Seneca valley virus based compositions and methods for treating disease
04/07/2005WO2005030122A2 Inactivated host cell delivery of polynucleotides encoding immunogens
04/07/2005WO2005029944A2 Refined plant transformation
04/07/2005WO2005016960A3 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
04/07/2005WO2005012535A3 Method for producing life attenuated viruses and use of viral particles thus produced.
04/07/2005WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation
04/07/2005WO2005012305A3 Tricyclic parp inhibitors
04/07/2005WO2005003354A3 Methods and means for regulating gene expression
04/07/2005WO2004111608A3 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
04/07/2005WO2004108760A3 Improved secretion of neublastin
04/07/2005WO2004103067A3 A transgenic animal model for cancer and stem cells
04/07/2005WO2004097017A3 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
04/07/2005WO2004096976A3 Spex compositions and methods of use
04/07/2005WO2004081033A3 Synthesis of proteins by cell-free protein expression
04/07/2005WO2004069875A3 Immunoglobulin anti integrin
04/07/2005WO2004066947A3 Hyperthermia oncolysis co-therapy
04/07/2005WO2004065594A3 Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof
04/07/2005WO2004053079A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins
04/07/2005WO2004044133A3 Modified oligonucleotides for use in rna interference
04/07/2005WO2004043978A3 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
04/07/2005WO2004041197A3 Methods of inhibiting glial scar formation
04/07/2005WO2004039988A9 Ppr peptide sequences capable of restoring male fertility of plants bearing a male sterility-inducing cytoplasm
04/07/2005WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE
04/07/2005WO2004010959A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
04/07/2005WO2004007695A3 Lactobacilli expressing biologically active polypeptides and uses thereof
04/07/2005WO2004003234A3 A system and method for snp genotype clustering
04/07/2005WO2004001072A3 Method for diagnosis of colorectal tumors
04/07/2005WO2003098186A3 Bioengineering cotton fiber properties
04/07/2005WO2003090689A3 Neurodegenerative disorder treatment using gdnf secreting neural cells
04/07/2005WO2003083443A3 Lipid mediated screening of drug candidates for identification of active compounds
04/07/2005WO2003070915A3 Mutated constitutively active nuclear orphan receptor
04/07/2005WO2003063688A3 Protein modification and maintenance molecules
04/07/2005WO2003062395A3 Predictor sets for tyrosine kinase pathways
04/07/2005WO2003057711A3 Isolated cytokine receptor licr-2
04/07/2005WO2003030612A3 Methods for modulating activity of the fxr nuclear receptor
04/07/2005WO2002066615A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
04/07/2005WO2002045659A3 Novel therapeutics for heart failure and aging
04/07/2005WO2001088089A8 Single copy genomic hybridization probes and method of generating same
04/07/2005US20050076412 Enhancing freeze, drought and/or salinity tolerance of agricultural crops; transforming with recombinant polynucleotide encoding C repeat/DRE binding factor related polypeptide and expressing into cells
04/07/2005US20050076411 Promoters functional in plant plastids
04/07/2005US20050076410 Expression vector comlprising nucleotide sequences coding nitric acid reductase (NOR) for use in transformation and generation of plants with enhance food ripening
04/07/2005US20050076409 Selective plant growth using d-amino acids
04/07/2005US20050076408 Expression vector comprising nucleotide sequences coding ripening inhibitor protein (RIN) for use as tool in transformation and propagation of plants w ith enhanced ripening
04/07/2005US20050076407 Plant defensin polynucleotides and methods of use thereof
04/07/2005US20050076406 Plant-derived resistance gene
04/07/2005US20050076405 Farnesyl pyrophosphate synthase proteins, nucleic acids and promoter regions therefor
04/07/2005US20050076404 Cell cycle polynucleotides, polypeptides and uses thereof
04/07/2005US20050076403 Production of syringyl lignin in gymnosperms
04/07/2005US20050076400 Transgenic animals exhibiting major disorders related to Alzheimer's disease
04/07/2005US20050076399 Using nuclear transplantation as tool in generating transgenic swine model which expresses green fluorescent protein and is defeicient in 1, 3 glactosyltransferase activity; bioreactors and heterologous gene expression
04/07/2005US20050076397 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
04/07/2005US20050076395 Transgenic mouse comprising nucleotide sequences coding immunoglobulin domains j, c, v and d for use as bioreactor in biosynthesis of human antibodies; immunodiagnostics
04/07/2005US20050075511 Prevention of human and/or animal viral, bacterial, fungal or parasitic infections; plant fungicides, bactericides and/or herbicides; reduced side effects; environmentally friendly; such as ((n-formyl-n-hydroxyamino)-methoxy)-methyl phosphonic acid disodium salt
04/07/2005US20050075496 Plasmodium falciparum antigens and their vaccine and diagnostic applications
04/07/2005US20050075495 Probes for chondrogenesis
04/07/2005US20050075492 Methods and products for expression of micro RNAs
04/07/2005US20050075489 DSP-5 dual-specificity phosphatase
04/07/2005US20050075488 Interleukin-1 beta antibodies
04/07/2005US20050075485 Neisseria meningitidis antigen
04/07/2005US20050075484 Construction and use of synthetic constructs encoding syndecan
04/07/2005US20050075307 Modulation of aminopeptidase N expression
04/07/2005US20050075306 Inhibition of Syk kinase expression
04/07/2005US20050075304 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
04/07/2005US20050075302 Administering a phosphorothioate oligonucleotide analog by inhalation, ophthalmic, intranasal, parenteral, oral or intradermal , wherein the phosphorothioate oligonucleotide analog is not antisense; anticarcinogenic and - tumor agents;surgical infections; immunopotentiation; O-alkyl modified
04/07/2005US20050075300 An expression vector comprising an enhancer sequence derived from the 3' untranslated variable number of tandem repeats domain of the dopamine transporter gene and a reporter gene and is capable of promoting the transcription of the reporter gene; Parkinson's; schizophrenia; gene therapy
04/07/2005US20050075299 Antisense modulation of wrn espression
04/07/2005US20050075291 mixture of anticoagulants and a protein C or activated protein C polypeptide comprising a modified gamma -carboxyglutamic acid (GLA) domain to enhance membrane binding receptivity, used for modulation of coagulation in mammals
1 ... 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 ... 4023